KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

Decroos, A.; Cheminant, M.; Bruneau, J.; Carras, S.; Parinet, V.; Pelletier, L.; Lacroix, L.; Martin, N.; Giustiniani, J.; Lhermitte, L.; Asnafi, V.; Battistella, M.; Lemonnier, F.; De Leval, L.; Sicard, H.; Bonnafous, C.; Gauthier, L.; Genestier, L.; Caruso, S.; Gaulard, P.; Hermine, O.; Ortonne, N.

doi:10.3324/haematol.2022.282220

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

Détails

Télécharger: 11076-Article Text-81046-2-10-20230927.pdf (1064.75 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0

ID Serval

serval:BIB_9494E12B88F0

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

Périodique

Haematologica

Auteur⸱e⸱s

Decroos A., Cheminant M., Bruneau J., Carras S., Parinet V., Pelletier L., Lacroix L., Martin N., Giustiniani J., Lhermitte L., Asnafi V., Battistella M., Lemonnier F., De Leval L., Sicard H., Bonnafous C., Gauthier L., Genestier L., Caruso S., Gaulard P., Hermine O., Ortonne N.

ISSN

1592-8721 (Electronic)

ISSN-L

0390-6078

Statut éditorial

Publié

Date de publication

01/10/2023

Peer-reviewed

Oui

Volume

108

Numéro

Pages

2830-2836

Langue

anglais

Notes

Publication types: Letter
Publication Status: epublish

Résumé

Not available.

Mots-clé

Humans, Lymphoma, T-Cell, Peripheral/drug therapy, Lymphoma, T-Cell, Peripheral/genetics, Receptors, KIR3DL2, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms/drug therapy

URN

urn:nbn:ch:serval-BIB_9494E12B88F02

OAI-PMH

oai:serval.unil.ch:BIB_9494E12B88F0

DOI

10.3324/haematol.2022.282220

Pubmed

37165836

Web of science

001109389400039

Open Access

Oui